Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.
about
Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiencyImpact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cellsTTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival, and tissue-specific gene expressionModeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platformMonocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.Genetic variation and clinical heterogeneity in cystic fibrosisInhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.Phosphorylated C/EBPβ influences a complex network involving YY1 and USF2 in lung epithelial cells.AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites.Cystic fibrosis: a mucosal immunodeficiency syndrome.Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.CFTR activity and mitochondrial function.Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cellsFoxa2 is required for transition to air breathing at birth.Oxidative stress modulates the expression of genes involved in cell survival in ΔF508 cystic fibrosis airway epithelial cells.Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.β-arrestin-2 regulation of the cAMP response element binding proteinHigh-content functional screen to identify proteins that correct F508del-CFTR function.Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins.Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.Epiregulin (EREG) is upregulated through an IL-1β autocrine loop in Caco-2 epithelial cells with reduced CFTR function.Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung.Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa.CFTR DeltaF508 mutation has minimal effect on the gene expression profile of differentiated human airway epithelia.Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney.Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice.Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls
P2860
Q24806288-620445F8-3CF5-44DC-9FF3-8DD2E1162AC4Q28181056-98823921-81BB-4391-9F61-F595377314B4Q28592144-2F28C49D-1C14-4D5A-BDFD-80BBC4397D3CQ28743135-ED9EA6CB-A7F5-4925-8061-E105402FFE8BQ33352036-135383CA-CB99-4D08-9768-CB271E8C284EQ33645546-4A5AA1E0-1A69-4E3E-8E81-36CA1EA75FAFQ34085307-BB65BAE7-3857-4AD6-BEA9-4AF0B87A37A2Q34359471-F95970BB-3371-40A6-876B-C90D228F2DB1Q34590648-606F213A-B326-47A1-8FBA-2117E7C1F042Q34656334-6D37FA74-264D-4122-8343-400C95C189E2Q35699580-E6EC2F1A-E848-48A8-806B-6220F41861F8Q36623329-05F49D6C-DD4E-4828-939E-ADF1A7137FAFQ37098637-7844EF6D-E143-46A5-8343-3DEFE2BE082CQ37133567-63F290B3-98C9-473E-B8E0-B3FE55F34F45Q37194960-7FC539F1-BF68-48AD-B1EF-969838157104Q37569076-DD86BFF0-C635-4036-BABA-D0FDF903D264Q38476313-853DBDFF-8C02-4B00-8F73-DBF8C7620011Q38518598-77F5DD22-F616-467F-8DEB-5285FCADE7B5Q39530054-0A07031C-E308-4E97-8565-5D0FB215D323Q39904574-B9CA12D3-52A2-402D-A6F9-A876A71F6744Q40621983-232007E9-8423-4A8C-B52D-F4CA3CEE7CE7Q40639006-2A2E1DC9-69B8-4C9E-A161-493863446291Q41819454-DA7CD675-CAD8-4699-9C9B-A44B9CB4B73CQ47578663-C87A0CF5-7FD6-46EE-B777-227304956C34Q47644235-00475363-8CA5-44DE-AD0C-1A725B52F132Q47762254-534ABA8B-2C9E-40FA-99F1-F8DB6314B795Q47785977-6AA5F991-BB93-480E-9E44-B94B742E2E57Q47981706-2512A67A-7C6E-43BD-A743-58EA311D9E4DQ54541591-5E875FE8-36FA-49E7-8F2B-E9C65AD3B2E2Q54621653-FC51E925-C045-4EAA-B295-550FA83C6ACDQ57374710-5EF90535-369D-40B7-AABC-A5901AF253E0
P2860
Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Transcriptional adaptation to ...... ductance regulator deficiency.
@en
type
label
Transcriptional adaptation to ...... ductance regulator deficiency.
@en
prefLabel
Transcriptional adaptation to ...... ductance regulator deficiency.
@en
P2093
P2860
P356
P1476
Transcriptional adaptation to ...... ductance regulator deficiency.
@en
P2093
Chitta R Dey
Jamie L Wooldridge
Jean C Clark
Jeffrey A Whitsett
P2860
P304
P356
10.1074/JBC.M210277200
P407
P577
2002-12-12T00:00:00Z